Why you should attend the International Liver Congress™ 2020
Every year, scientific and medical experts from a broad range of fields including hepatology, gastroenterology, internal medicine, cell biology, transplant surgery, infectious diseases, microbiology and virology, pharmacology, pathology and radiology and imaging come together from around the world to the International Liver Congress™ to learn about the latest in liver research.
- ILC is EASL’s annual flagship congress and attracts around 10,000 delegates and 250 media representatives from all over the world
- Specialists share recent data, present studies and findings
- Discuss the hottest topics on liver disease
- Excellent international networking opportunity
- Taking place in a vibrant scientific and culturally rich location
- Easily accessible by major transport networks
The International Liver Congress™ 2020 topic: A Healthy Liver for a Healthy You
At the International Liver Congress™ 2020, EASL is turning its attention to health in daily life and its importance in protecting the liver. Doctors, patients and patient groups, allied health professionals and policymakers will discuss the important new insights and information to help combat liver disease.
Attendees will hear the latest epidemiological and real-world data on the latest liver research.
ILC 2020 and EASL’s Principles and Values
EASL is committed to furthering research in the field of hepatology to improve the lives of everyone affected by liver disease. The combined efforts of all stakeholders in the public and private sectors, and civil society are essential to halting and reversing liver disease. As such, EASL acknowledges that every voice is valued.
EASL embraces freedom of expression during the International Liver Congress™ as an essential principle in the response to progressing liver disease and in promoting full participation during the congress. However, EASL is responsible for maintaining the safety of all attendees and as such, must balance the need of allowing all participants to be heard while ensuring the Congress is not disrupted.
In September 2019 EASL launched a policy statement on equality, diversity and inclusion.
02 April 2020
EASL-ESCMID Position Paper: Patients with advanced liver disease and transplant recipients require specific care during COVID-19
The European Association for the Study of the Liver (EASL) and the European Society of Clinical Microbiology and…
23 March 2020
EASL encourages healthcare professionals to share the COVID-Hep registry among its networks. COVID-Hep is a new registry that has been…
13 March 2020
13 March Given the ongoing developments with COVID-19, EASL has postponed the International Liver CongressTM (ILC 2020) that…